Search tips
Search criteria 


Logo of cytotechspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
Cytotechnology. 2002 January; 38(1-3): 99–108.
PMCID: PMC3449917

A new seed-train expansion method for recombinant mammalian cell lines


A new approach has been developed and used to minimize the timeand more carefully monitor and control the seed-train expansionprocess of recombinant mammalian cell lines. The process uses 50or 100 ml cryo-bags that contain frozen cells at high cell densities of 20 × 106 ml-1 (100 ml bags) or 40 × 106 cells ml-1 (50 ml bags). The frozen bag cell suspension is thawed and transferred directly into a bioreactorthat has been modified such that pH, DO and temperature can becontrolled at the initial volume of two liters (the working volume eventually increases to 12 l). The successful use of thesecryo-bags and the modified `inoculation' bioreactor to initiate anew seed train expansion of rBHK or rCHO cells is described herein. The interval between cell thawing and the accumulation ofsufficient cell mass to inoculate a production reactor is reducedby at least 25 to 30 days compared to the conventional method that begins with the thaw of 1–2 ml cryo-vials. This `one-step'technology leads to a much more consistent scale-up by reducingmanual operations and avoiding subjective decisions during the scale-up phase. The cell metabolic rates and product integritywere similar to the control experiments. Furthermore, it was found that it is not necessary to include a wash step to removeDMSO prior to the inoculation.

Full Text

The Full Text of this article is available as a PDF (375K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Avis KE, Wagner CM. Drug Manufacturing Technology Series. Denver, Colorado: Interpharm Press; 1999. Cryopreservation – Applications in Pharmaceuticals and Biotechnology.
  • Chuppa S, Tsai Y-S, Yoon S, Shackleford S, Rozales C, Bhat R, Tsay G, Matanguihan C, Konstantinov K, Naveh D. Fermentor temperature as a tool for control of high-density perfusion cultures of mammalian cells. Biotechnol Bioeng. 1997;55:328–338. [PubMed]
  • Diener B, Utesch D, Beer N, Dürk H, Oesch F. A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics. Cryobiology. 1993;30:116–127. [PubMed]
  • Fennema OR, Powrie WD, Marth EH. Low-temperature Preservation of Food and Living Matter. New York: Marcel Dekker, Inc.; 1973.
  • Franks F (1985) Biophysics and Biochemistry at Low Temperatures. Cambridge University Press.
  • Franks F. Freeze-drying: From empiricism to predictability: The significance of glass transitions. Karger, Basel. Dev Biol Stand. 1991;74:9–19. [PubMed]
  • Grout B, Morris J, McLellan M. Cryopreservation and the maintenance of cell lines. Trends Biotechnol. 1990;8:293–297. [PubMed]
  • Heidemann R, Zhang C, Qi H, Rule J, Rozales C, Park S, Chuppa S, Ray M, Michaels J, Konstantinov K, Naveh D. The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells. Cytotechnology. 2000;32:157–167. [PMC free article] [PubMed]
  • Heldman DR, Singh RP. Food Process Engineering. 2nd ed. Westport, Connecticut: The AVI Publishing Company, Inc.; 1981. pp. 178–184.
  • Lindl T & Bauer J (1989) Zell-und Gewebekultur. 2. Aufl. Gustav Fischer Verlag.
  • Morgan SJ, Darling DC. Animal Cell Culture. Oxford: Bios Scientific Publishers; 1993.
  • Ninomiya N, Shirahata S, Murakami H, Sugahara T. Largescale, high density freezing of hybridomas and its application to high-density culture. Biotechnol Bioeng. 1991;38:1110–1113. [PubMed]
  • Re A, Vijayaraghhavan K, Basade M, He S, Gulati S. Long-term cryopreservation: Successful trilineage engraftment after autologous bone marrow transplantation with bone marrow cryopreserved for seven years. J Hematotherapy. 1998;7:185–188. [PubMed]
  • Regidor C, Posada M, Monteagudo D, Garauled C, Somolinos N, Forés R, Briz M, Fernández M. Stem cell transplantation. Exp Hematology. 1999;27:380–385. [PubMed]
  • Siegel WH. Cryopreservation of Mammailian Cell Cultures. In: Avis KE, Wagner CM, editors. Cryopreservation – Applications in Pharmaceuticals and Biotechnology. Drug Manufacturing Technology Series. Denver, Colorado: Interpharm Press; 1999.
  • Thrift J, Tsai Y, Lowe B, Ng M, Michaels J, Hey J & Konstantinov, K (2000) Development and Optimization of Protein-free Cell Banking Technology. Proceedings of the Cell Culture Engineering VII Foundation Meeting, Santa Fee, NM, 5–10 February.
  • Whitaker SC, Francis R & Siegel RC (1998) Validation of Continuously Perfused Cell Culture Processes for Production of Monoclonal Antibodies. In Kelly BD and Ramelmeier A (eds) Validation of Biopharmaceutical Manufacturing Processes. American Chemical Society, pp. 28–43.
  • Wu L, Sun J, Wang L, Woodman K, Koutalistras N, Horvat M, Sheil AGR. Cryopreservation of primary porcine hepatocytes for use in bioartificial liver support systems. Transplantation Proc. 2000;32:2271–2272. [PubMed]
  • Wu L, Sun J, Wang L, Woodman K, Koutalistras N, Horvat M, Sheil AGR. Cryopreserved porcine hepatocytes in a liver biodialysis system. Transplantation Proc. 2001;33:1950–1951. [PubMed]
  • Zachariou M, Mazer J, Park H & Olson C (2001) Method for Evaluating Target Protein Quality from Fermenter. US Patent 6,214,975 B1.

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.